Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 17 - Number 3
Biography Open Access
Editorial Open Access
Review Article
Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review
, 17(3): 201 - 213Pouran Makhdoumi, Hooshyar Hossini*, Ghulam Md Ashraf * and Mojtaba Limoee
DOI: 10.2174/1570159X16666180803164238
Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review
Review Article
Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis
, 17(3): 214 - 231Faheem Hyder Pottoo*, Md. Noushad Javed, Md. Abul Barkat, Md. Sabir Alam, Javaid Ashraf Nowshehri, Dhafer Mahdi Alshayban and Mohammad Azam Ansari*
DOI: 10.2174/1570159X16666180628164432
Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis
Review Article
Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
, 17(3): 232 - 246Mahmood Ahmad Khan*, Qamre Alam, Absarul Haque, Mohammad Ashafaq, Mohd Jahir Khan, Ghulam Md Ashraf* and Mahboob Ahmad
DOI: 10.2174/1570159X16666180828100002
Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
Review Article
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
, 17(3): 247 - 267Muneeb U. Rehman, Adil Farooq Wali, Anas Ahmad, Sheeba Shakeel, Saiema Rasool, Rayeesa Ali, Shazada Mudasir Rashid, Hassan Madkhali, Majid Ahmad Ganaie and Rehan Khan*
DOI: 10.2174/1570159X16666180911124605
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Review Article
Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
, 17(3): 268 - 287Yulia A. Sidorova*, Konstantin P. Volcho* and Nariman F. Salakhutdinov
DOI: 10.2174/1570159X16666180905094123
Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
Review Article
Alzheimer’s Disease – Future Therapy Based on Dendrimers
, 17(3): 288 - 294Gjumrakch Aliev*, Ghulam Md Ashraf , Vadim V. Tarasov, Vladimir N. Chubarev, Jerzy Leszek, Kazimierz Gasiorowski, Alfiya Makhmutovа, Saleh Salem Baeesa, Marco Avila-Rodriguez, Aleksey A. Ustyugov and Sergey O. Bachurin
DOI: 10.2174/1570159X16666180918164623
Alzheimer’s Disease – Future Therapy Based on Dendrimers
Review Article
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
, 17(3): 295 - 306Iván Carrera* and Ramón Cacabelos
DOI: 10.2174/1570159X17666181127125704
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net